Statement on the House Appropriations Committee Passage of the Fiscal Year 2026 Defense Appropriations Act Yesterday, the House Appropriations Committee approved its version of the Fiscal Year (FY) 2026 Defense Appropriations Act. The chairman’s mark allocates $700 million as [...]
We are deeply concerned that the President’s Fiscal Year 2026 (FY26) budget does not reflect the public’s call for sustained and robust investments in cancer research. Instead, it threatens to reverse decades of progress. On Friday, May 30, 2025, [...]
Lung cancer remains the leading cause of cancer deaths in every state, nationwide. In 2025, it is estimated that more people will die from lung cancer than from breast and colorectal cancers combined. Despite this fact, lung cancer continues [...]
A statement from GO2 for Lung Cancer’s President and CEO Laurie Ambrose on the proposed federal budget cuts The President recently submitted a Fiscal Year 2026 budget request that proposes yet again deep cuts to and elimination of key [...]
GO2 for Lung Cancer remains at the forefront of leading advocacy efforts to restore funding for the Lung Cancer Research Program. In preparation for today’s Senate Appropriations Committee hearing, “Biomedical Research: Keeping America’s Edge in Innovation,” we submitted written [...]
In early March, we surveyed the GO2 community to understand how recent federal executive orders are affecting patients, loved ones, healthcare providers, and researchers. Themes from 239 completed surveys covered 4 key areas: Impact on daily life or work [...]
The GO2 Lung Cancer Voices Summit, held March 9-11 in Washington, D.C., mobilized nearly 200 patients, survivors, caregivers, and advocates from more than 30 key states in a powerful call for action on Capitol Hill. Focused on securing the [...]
A statement from GO2 President and CEO Laurie Ambrose I remember the day vividly in 2008. I succeeded in organizing a meeting with the Chairman of the House Appropriations Defense Subcommittee, Congressman John Murtha, to discuss establishing a dedicated [...]
GO2 for Lung Cancer stands alongside patients, families, healthcare providers, researchers, and the broader medical community in our mission to increase survival for those at risk, diagnosed, and living with lung cancer. On January 27, 2025, the Office of [...]
Yesterday, the Women and Lung Cancer Research and Preventive Services Act (H.R. 4534/S. 2245) achieved a historic milestone and passed out of the House of Representatives. We thank the bill leaders, Congressman Brendan F. Boyle (D-PA-02) and Congressman Brian [...]